Your statement is just pure junk. The company owns the goods and all patent art. Who cares if combinations work better. The product is still sold. All iterations going forward benefit NWBO.
“And her recent adaptation works, indicates that DCVAX-L was far from a viable finished product, and a clear indication that she has processionally & academically stepped away from Northwest BioTherapeutics. “
You don't know what you're talking about, but like I said, crazy stalkers can be determined.
1. Dr. Liau is on the Scientific Advisory Board https://nwbio.com/northwest-biotherapeutics-announces-that-dr-linda-liau-has-joined-the-companys-scientific-advisory-board/ ; 2. NWBO owns this tech and the advances that come from it are about adding other treatments and drugs and the deal they have with UCLA is that improvements are licensed, that is how these deals work, hence the combination patent, which addresses exactly what is happening at UCLA. 3. NWBO has actually advanced the manufacturing (hence flaskworks, etc.), something that UCLA is not equipped to do, so you're flatly wrong on that issue, you clearly post these things just to make people anxious which makes you not just a pointless stalker seeking attention, but given that this treatment is actually for people with a deadly disease, not clowns like you who go off pretending they know something about a disease they actually DID NOT HAVE, your behavior makes the activity you engage in here, akin to what a sadistic psychopath would do... 4. There is no further advancement that has been done at UCLA. There are trials in combination with drugs for which the company and UCLA had and have a patent claim. Even for initial patent claims not protected, the initial filing ensures that no one else can make broader claims that were not yet granted and, of course, the owners can file to revive claims previously made in the patent family. In the meantime, it ensures that NWBO and UCLA have an open path without fear of someone else making those same patent claims. You have shown you know very little about this product or its results but you continue to pretend that you do. You go from making absurd claims that you're directly in touch with MHRA, that you're a government official, that you're a retired government official, that you have inside information of investigations by governments, and that says you're nuts and a bizarre character with a tendency at paranoia and delusions of grandeur. 6. And of course now they have the collaboration with Roswell, and they have some really interesting and impressive different trials and patents related to dendritic cells and nuances to treatment. That should add immense value to the company and the company's bag of tricks, in the long-run. Roswell has some really great additional technologies and NWBO is the perfect partner to advance those ideas and technologies. https://nwbio.com/northwest-biotherapeutics-announces-exclusive-in-license-of-portfolio-of-dendritic-cell-technology-and-intellectual-property/
But hey, psychos with delusions of grandeur and paranoia add a little spice in the world.
This opinion is worthless and has no foundation of truth whatsoever. In fact, Dr. Linda Liau and her team are growing at UCLA by leaps and bounds over the last 3 years. Furthermore, Dr. Linda Liau and her team are continuing their researching multiple cancer types based on DCVAX-L. DCVax-D has great potential for many solid tumors as well and this could change current SOC forever, IMPO.
The great news is that DCVAX with additional compounds appears to be extending the percent factor for long term cancer survival.
So, the real issue is that increasing their cancer research continues to provide positive results. As for investing in NWBO, I would rather invest and accumulate more NWBO shares, IMPO.
Your comments are total BS, IMPO. It is a fact that many cancer facilities and oncologist doctors support what Northwest Biotherapeutics has accomplish and will continue to accomplish.
News 
Market Data 
Discover 
AI
